Azitra, Inc. (NYSEAMERICAN:AZTR – Get Free Report)’s share price was up 14% on Friday . The stock traded as high as $0.47 and last traded at $0.46. Approximately 1,572,722 shares changed hands during trading, an increase of 94% from the average daily volume of 809,416 shares. The stock had previously closed at $0.41.
Azitra Stock Performance
Azitra (NYSEAMERICAN:AZTR – Get Free Report) last released its quarterly earnings results on Tuesday, November 12th. The company reported ($0.17) EPS for the quarter, topping analysts’ consensus estimates of ($0.48) by $0.31. Equities research analysts anticipate that Azitra, Inc. will post -2.78 earnings per share for the current year.
About Azitra
Azitra, Inc, an early-stage biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease.
Further Reading
- Five stocks we like better than Azitra
- How is Compound Interest Calculated?
- S&P 500 ETFs: Expense Ratios That Can Boost Your Long-Term Gains
- Breakout Stocks: What They Are and How to Identify Them
- How AI Implementation Could Help MongoDB Roar Back in 2025
- What is MarketRank™? How to Use it
- Hedge Funds Boost Oil Positions: Is a Major Rally on the Horizon?
Receive News & Ratings for Azitra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azitra and related companies with MarketBeat.com's FREE daily email newsletter.
-etf-logo-1200x675.png?v=20240923123417&h=54&w=95&zc=2){kind=logo}
